Deals of the day-Mergers and acquisitions

Incyte

08/06/2026 10:34

June 8 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 0930 GMT on Monday:
     
** U.S. group Ingredion <INGR.N> has struck a deal to buy Britain's Tate & Lyle <TATE.L> for £2.7 billion ($3.6 billion) in cash to create a leading speciality food and beverage ingredients company.
nL6N42G0CY
     
** Intesa Sanpaolo <ISP.MI> has taken a 3% stake in Generali <GASI.MI> to prevent the insurer from building a defensive stake in Italy's biggest bank, CEO Carlo Messina told analysts.
nS8N3EV02A
     
** Italy's biggest banking group Intesa Sanpaolo <ISP.MI> said it has made a €30.6 billion ($35 billion) unsolicited cash-and-share bid to buy smaller rival Monte dei Paschi di Siena (MPS) <BMPS.MI> in Italy's biggest banking deal ever.
nL4N42G0DE
     
** U.S. biotech Incyte Pharma <INCY.O> is nearing a deal for up to $2 billion to buy blood disorder drug developer Star Therapeutics, the Financial Times reported on Sunday, citing people familiar with the matter.
nL1N42F02C
     

(Compiled by Rajarshi Roy and Megavarshini G. Somasundaram in Bengaluru)
((Rajarshi.Roy@thomsonreuters.co))